The leukodystrophy drug Industry is entering a transformative phase. This specialized sector, focused on treating a group of more than 50 rare, inherited neurological disorders , is witnessing a profound shift away from supportive care toward curative genetic treatments. This move is projected to drive robust growth, with the market expected to expand at a steady Compound Annual Growt... https://www.databridgemarketresearch.com/reports/global-leukodystrophy-drug-market?utm_source=onkar&utm_medium=organic&utm_campaign=hc&utm_id=global-leukodystrophy-drug-market